At Crown Bioscience, we are driven by our mission to ensure that every patient gets the right treatment at the right time. That is why we are trusted by the world’s leading biopharmaceutical companies to advance their preclinical and translational research programs. With our extensive experience in the areas of oncology, immuno-oncology, and immune-mediated inflammatory diseases. Leverage the infinite possibilities of scientific innovation.
Accelerate your oncology program using our comprehensive suite of in vivo, in vitro and ex vivo biological services
Advance IMID drug development with our integrated preclinical platform for diseases such as IBD, Rheumatoid Arthritis and Diabetes
Explore a unique collection of validated syngeneic, mouse tumor homograft models, and humanized genetically engineered mouse models
Discover a unique high content screening platform for Autosomal Dominant Polycystic Kidney Disease to enable the recapitulation of the in vivo disease phenotype